Comparative Study of Efficacy and Safety of Dapagliflozin vs Basal Insulin in Stabilizing Glycemic Variability in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Triple Drug Combination Therapy
Insulin glargine, as the fourth glucose-lowering agent on the background of a triple drug regimen, has demonstrated a significant reduction in GV compared to that observed with dapagliflozin.
Authors
- Satish Shelke
- Bhakti Chandekar
- Deepak S. Bhosle
Institutions
- Mahatma Gandhi Mission Medical College and Hospital (IN)
Publication Details
- Journal
- Journal of the Association of Physicians of India
- Published
- 2025-04-01
- DOI
- https://doi.org/10.59556/japi.73.0925
- Citations
- 1
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.29